Not Verified

Psoriatic Arthritis/Ankylosing Spondylitis Research Grant

Arthritis National Research Foundation

The ANRF is pleased to announce the release of the 2027 Psoriatic Arthritis /Ankylosing Spondylitis Research Grant Application. This grant aims to provide financial support to early career researchers, studying psoriatic arthritis/ankylosing spondylitis and/or related mechanisms, who are within a few years of their transition to independence.

Grants will be funded for 2 years and awarded up to a total of $250,000. We invite researchers and innovators from diverse fields to submit their grant applications for this funding opportunity.

Background:

Psoriatic arthritis affects 1.5 million people in the United States. This disease and its underlying mechanisms are incredibly complex and require innovative research to better understand their pathology. There is a pressing need for more talented investigators to join the fields of dermatology, rheumatology and immunology to tackle these challenges. Therefore, ANRF has spent the last 50+ years dedicating grant funding to early career researchers looking to make impacts towards cures of these disease states.

Goal:

ANRF is committed to nurturing the next generation of leaders in arthritis and autoimmune disease research. We are pleased to provide the opportunity to support early career researchers in their pursuit of innovative and impactful research projects. Our goal is to support exceptional researchers at the key point in their career as they transition to independence to allow them the resources to make significant advances in research of arthritis and related autoimmune disease.

Scope:

This call is for all types of applications relating to psoriatic arthritis/ankylosing spondylitis and their underlying mechanisms. If you are studying another form of arthritis or autoimmune disease, please review the Arthritis and Related Autoimmune Disease Research Grant Application at https://curearthritis.org/research-grants/.

AI Based Application Success Predictor

1. Direct relevance to arthritis and related autoimmune diseases ⭐⭐⭐⭐⭐

This is the fundamental fit requirement.

ANRF supports research across arthritis, rheumatic and autoimmune diseases. Its funded portfolio includes areas such as rheumatoid arthritis, osteoarthritis, lupus, juvenile arthritis, psoriatic arthritis, ankylosing spondylitis/spondyloarthritis, scleroderma and other inflammatory or autoimmune disorders.

Strong projects therefore usually address:

Rheumatoid arthritis
Osteoarthritis
Psoriatic arthritis
Juvenile idiopathic arthritis
Ankylosing spondylitis/spondyloarthritis
Lupus
Scleroderma/systemic sclerosis
Gout
Autoimmune/inflammatory mechanisms
Joint inflammation and damage
Bone/cartilage biology
Immune-mediated rheumatic disease

Predictor strength: Very High.

2. Scientific significance and potential impact ⭐⭐⭐⭐⭐

The proposal should tackle an important problem rather than simply generate additional descriptive information.

The strongest application explains:

Disease problem → important knowledge gap → proposed discovery → potential impact on arthritis/autoimmune disease

ANRF describes its grants as supporting projects capable of uncovering underlying disease mechanisms, identifying treatments and ultimately improving patients' lives.

A reviewer should immediately understand why the research matters.

3. Innovation and originality ⭐⭐⭐⭐⭐

Innovation is particularly important for ANRF.

The Foundation emphasizes funding emerging scientists with innovative research proposals and supports work ranging from understanding disease mechanisms to developing new therapies.

Strong proposals may introduce:

Novel disease mechanisms
New therapeutic targets
Innovative biomarkers
New immune pathways
New technologies
Precision-medicine approaches
Novel cell or molecular targets
New approaches to preventing joint damage
Innovative translational strategies

For ANRF, a high-risk/high-potential idea with convincing scientific reasoning can be especially attractive for an early-career researcher.

4. Strong scientific approach and methodological rigor ⭐⭐⭐⭐⭐

Innovation alone is insufficient. The project must also be technically convincing.

Competitive proposals should demonstrate:

Clear hypothesis
Specific aims
Appropriate experimental design
Suitable controls
Appropriate statistical analysis
Reproducibility
Realistic sample sizes
Appropriate models or patient populations
Potential problems and alternative strategies
Achievable milestones

ANRF publishes dedicated reviewer scoring criteria and a grant-writing guide specifically to help investigators develop competitive applications.

5. Early-career investigator potential ⭐⭐⭐⭐⭐

This is one of the most distinctive ANRF success predictors.

ANRF's funding model specifically emphasizes supporting early-career scientists and helping them establish sustainable research careers.

A strong candidate therefore demonstrates:

Excellent scientific training
Emerging publication record
Research productivity
Clear commitment to arthritis/autoimmune research
Potential to establish an independent program
Appropriate technical expertise
A coherent long-term research direction

This makes ANRF particularly attractive for investigators who have strong potential but have not yet accumulated major independent funding.

6. Potential to establish research independence ⭐⭐⭐⭐⭐

ANRF funding should ideally function as a career-launching investment.

The Foundation reports that its support is intended to help early-career investigators establish sustainable careers, while its historical experience shows that funded researchers frequently continue working in arthritis and immunological research.

A compelling trajectory is:

Promising investigator → ANRF grant → preliminary discoveries → publications → larger external grant → independent laboratory/research program

This is particularly important when describing the applicant's career trajectory.

7. Potential for future NIH/government funding ⭐⭐⭐⭐⭐

ANRF seed funding has historically been leveraged into substantially larger external awards. ANRF reported that its recipients had obtained more than $20 in subsequent government funding for every dollar of ANRF support in one historical analysis.

Therefore, reviewers are likely to value projects capable of generating:

Strong preliminary data
Publications
New hypotheses
Proof-of-concept results
Data supporting NIH applications
Larger clinical/translational studies

A particularly compelling proposal makes clear what next grant/application becomes possible if the ANRF project succeeds.

8. Potential for new treatments or disease understanding ⭐⭐⭐⭐⭐

ANRF's mission encompasses both understanding disease mechanisms and moving toward improved treatments and cures.

This means both of these pathways can be competitive:

Basic: mechanism → biological discovery → therapeutic target

Translational: discovery → biomarker/therapy → validation → improved treatment

A basic-science proposal does not necessarily need immediate clinical application, but it should clearly explain how the discovery advances understanding of arthritis or autoimmune disease.

9. Strong research environment and mentorship ⭐⭐⭐⭐☆

Early-career researchers need an environment capable of supporting the proposed science.

Important elements include:

Appropriate laboratory
Required equipment
Relevant patient/sample access
Experienced mentor(s)
Technical expertise
Biostatistical support
Collaborators
Institutional resources

ANRF's broader program explicitly emphasizes mentorship, collaboration and career development among emerging rheumatology investigators.

The environment should complement the investigator rather than overshadow them—the proposal should still demonstrate the applicant's intellectual ownership.

10. Exact fit with the specific ANRF mechanism ⭐⭐⭐⭐⭐

ANRF now offers several distinct programs rather than one generic research grant. Its current grants page lists awards ranging from $50,000 to $250,000 and projects lasting one to two years.

Specialties

Dermatology

Eligibility Requirements

An applicant can be awarded this grant only once.

This is a career development award. Applicants should expect to participate in an active cohort with the Arthritis National Research Foundation designed to help researchers meet their career goals.

ANRF will consider applications researching basic or clinical studies. Clinical studies should have a translational component that helps reveal the underlying mechanisms or response to therapy. ANRF is looking to award one (1) application focusing on psoriatic arthritis and one (1) application focusing on ankylosing spondylitis in 2027.

Applicants may not have, or ever had, an NIH R01 grant or equivalent.

Applicants must be affiliated with, and complete all grant-funded research at, a qualified U.S. nonprofit research institution. Applicants are not required to be U.S. citizens.

Sponsor Details

Sponsor Institute/Organizations: Arthritis National Research Foundation

Sponsor Type: Corporate/Non-Profit

Address: 5319 University Drive #10022, Irvine, CA 92612

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity